Collectively, these data suggest that dunnione alleviates breast cancer-associated lung thrombosis by inhibiting the expression of tissue factor through the NAD+/SIRT1/acetyl-NF-κB/tissue factor axis in vivo. The gene discussed is NFKB1; the disease is breast cancer.